Skip to content
goodwin-final-color Color Goodwin logo
  • Manufacturing Solutions
    • Analytical Method Development
    • Clinical GMP Manufacturing Services
    • Upstream Development
    • Downstream Development
    • Aseptic Fill & Finish
    • Bioconjugation
  • Support Solutions
    • Regulatory & CMC Support
    • Quality Control
    • Quality Assurance
    • Project Management
    • Consulting Services
    • Cell Line Development
  • Applications
    • COVID-19
    • Exosomes
    • Biosimilars & Biobetters
    • Multispecific Antibodies & Antibody Fragments
  • About
    • Who We Are
    • Leadership
    • Board of Directors
    • Facilities and Location
    • Why Goodwin Biotechnology?
    • Goodwin Awards
    • Collaborations & Partnerships
    • News
      • Press Releases
      • Upcoming Events
      • In the News
      • Publications & Patents
    • Careers
  • Contact Us
  • Manufacturing Solutions
    • Analytical Method Development
    • Clinical GMP Manufacturing Services
    • Upstream Development
    • Downstream Development
    • Aseptic Fill & Finish
    • Bioconjugation
  • Support Solutions
    • Regulatory & CMC Support
    • Quality Control
    • Quality Assurance
    • Project Management
    • Consulting Services
    • Cell Line Development
  • Applications
    • COVID-19
    • Exosomes
    • Biosimilars & Biobetters
    • Multispecific Antibodies & Antibody Fragments
  • About
    • Who We Are
    • Leadership
    • Board of Directors
    • Facilities and Location
    • Why Goodwin Biotechnology?
    • Goodwin Awards
    • Collaborations & Partnerships
    • News
      • Press Releases
      • Upcoming Events
      • In the News
      • Publications & Patents
    • Careers
  • Contact Us

News

News

Goodwin Biotechnology featured on Worldwide Business with kathy ireland®

  • December 23, 2020

Goodwin Biotechnology CEO Karl Pinto on Delivering Integrated Manufacturing Solutions for Complex Biopharmaceuticals

  • October 19, 2020

AST and Goodwin Biotechnology Partner on a GENiSYS® C20 Aseptic Small Batch Filling & Closing Machine

  • September 14, 2020

GigaGen Initiates Large-Scale Manufacturing of its First-in-Class Recombinant Hyperimmune Drug for COVID-19, GIGA-2050

  • September 9, 2020

Goodwin Biotechnology Launches a Digitization Initiative by Investing in a Sophisticated Electronic Quality Solution

  • November 6, 2019
1 2 3 … 13 Next

1850 N.W. 69th Avenue Plantation, FL 33313 USA 800-814-8600

  • Facebook
  • Twitter
  • LinkedIn
  • Manufacturing Solutions
    • Analytical Method Development
    • Clinical GMP Manufacturing Services
    • Upstream Development
    • Downstream Development
    • Aseptic Fill & Finish
    • Bioconjugation
  • Support Solutions
    • Regulatory & CMC Support
    • Quality Control
    • Quality Assurance
    • Project Management
    • Consulting Services
    • Cell Line Development
  • Applications
    • COVID-19
    • Exosomes
    • Biosimilars & Biobetters
    • Multispecific Antibodies & Antibody Fragments
  • Who We Are
    • Who We Are
    • Leadership
    • Board of Directors
    • Facilities & Location
    • Why Goodwin Biotechnology?
    • Goodwin Awards
    • Collaborations & Partnerships
    • News
    • Careers
© 2021 Goodwin Biotechnology Inc. All rights Reserved.
  • Privacy Policy
  • Sitemap